TMCI
TREACE MEDICAL CONCEPTS, INC.
Next earnings Aug 5, 2026 (after close) · consensus $-0.30 EPS, $44.9M rev
Last earnings +4.7% on 2026-05-08
$4.45
▲ +7.75%$4.45▼ -19.24%
over 1Y
L $1.20EODHDH $7.70
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.7%
1W+6.2%
1M+57.2%
3M+247.7%
YTD+78.0%
1Y-19.2%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Sell
Unprofitable (net margin -27.7%).
TREACE MEDICAL CONCEPTS, INC. shows $213M in FY2025 revenue (+1.6% YoY), a -27.7% net margin, and -67.6% ROE.
Sources: SEC EDGAR (CIK 0001630627, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 12:45:13 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.